Holders — by stockHoldings — by fund
Ikarian Capital, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001778253
$928.2M
disclosed book value
137
positions
5.1%
largest position share
Positions, as of 2026-06-30
top 100 of 137 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | XBISPDR SERIES TRUSTPUT | 300,000 | $47.5M | 5.1% |
| 2 | ABVXABIVAX SACALL | 341,100 | $45.5M | 4.9% |
| 3 | ABVXABIVAX SA | 328,635 | $43.4M | 4.7% |
| 4 | KODKODIAK SCIENCES INC | 1.1M | $41.3M | 4.4% |
| 5 | ABVXABIVAX SAPUT | 250,000 | $33.3M | 3.6% |
| 6 | IONSIONIS PHARMACEUTICALS INCCALL | 400,000 | $31.7M | 3.4% |
| 7 | MRNAMODERNA INCPUT | 400,000 | $28.0M | 3% |
| 8 | ALMSALUMIS INC | 870,548 | $24.5M | 2.6% |
| 9 | PRAXPRAXIS PRECISION MEDICINES I | 72,842 | $24.4M | 2.6% |
| 10 | IONSIONIS PHARMACEUTICALS INCPUT | 300,000 | $23.8M | 2.6% |
| 11 | PCVXVAXCYTE INC | 388,682 | $22.6M | 2.4% |
| 12 | ANIPANI PHARMACEUTICALS INC | 272,085 | $22.5M | 2.4% |
| 13 | CLDXCELLDEX THERAPEUTICS INC NEW | 478,500 | $17.8M | 1.9% |
| 14 | RCUSARCUS BIOSCIENCES INC | 504,559 | $15.6M | 1.7% |
| 15 | RLMDRELMADA THERAPEUTICS INC | 2.1M | $14.9M | 1.6% |
| 16 | CAPRCAPRICOR THERAPEUTICS INC | 604,215 | $14.5M | 1.6% |
| 17 | COGTCOGENT BIOSCIENCES INC | 370,084 | $14.3M | 1.5% |
| 18 | NEWAMSTERDAM PHARMA COMPANYPUT | 400,000 | $13.6M | 1.5% |
| 19 | VERAVERA THERAPEUTICS INC | 310,000 | $13.3M | 1.4% |
| 20 | CTNMCONTINEUM THERAPEUTICS INC | 807,874 | $13.2M | 1.4% |
| 21 | TENXTENAX THERAPEUTICS INC | 787,600 | $11.5M | 1.2% |
| 22 | CCCCC4 THERAPEUTICS INC | 2.4M | $11.4M | 1.2% |
| 23 | MAZEMAZE THERAPEUTICS INC | 378,999 | $11.3M | 1.2% |
| 24 | BIOHAVEN LTD | 748,181 | $11.1M | 1.2% |
| 25 | CONNECT BIOPHARMA HLDGS LTD | 4.5M | $10.8M | 1.2% |
| 26 | ANROALTO NEUROSCIENCE INC | 407,338 | $10.7M | 1.2% |
| 27 | PHARVARIS N V | 308,856 | $10.7M | 1.2% |
| 28 | ALMSALUMIS INCCALL | 356,300 | $10.0M | 1.1% |
| 29 | JBIOJADE BIOSCIENCES INC | 427,349 | $9.5M | 1% |
| 30 | DAMORA THERAPEUTICS INC | 335,710 | $8.7M | 0.9% |
| 31 | KODKODIAK SCIENCES INCCALL | 217,700 | $8.5M | 0.9% |
| 32 | CAPRCAPRICOR THERAPEUTICS INCCALL | 350,000 | $8.4M | 0.9% |
| 33 | ARWRARROWHEAD PHARMACEUTICALS INPUT | 100,000 | $8.2M | 0.9% |
| 34 | VRDNVIRIDIAN THERAPEUTICS INC | 425,000 | $7.8M | 0.8% |
| 35 | PTHSPELTHOS THERAPEUTICS INC | 256,598 | $7.3M | 0.8% |
| 36 | ZURA BIO LTD | 1.2M | $7.2M | 0.8% |
| 37 | TECXTECTONIC THERAPEUTIC INC | 205,837 | $7.1M | 0.8% |
| 38 | PRAXPRAXIS PRECISION MEDICINES ICALL | 20,000 | $6.7M | 0.7% |
| 39 | SPRBSPRUCE BIOSCIENCES INC | 121,356 | $6.6M | 0.7% |
| 40 | HIMSHIMS & HERS HEALTH INC | 188,381 | $6.5M | 0.7% |
| 41 | ELVNENLIVEN THERAPEUTICS INC | 126,541 | $6.4M | 0.7% |
| 42 | PROQR THRAPEUTICS N V | 3.4M | $6.4M | 0.7% |
| 43 | DRUGBRIGHT MINDS BIOSCIENCES INC | 88,951 | $6.2M | 0.7% |
| 44 | OVIDOVID THERAPEUTICS INC | 2.3M | $6.1M | 0.7% |
| 45 | OCGNOCUGEN INC | 4.0M | $6.1M | 0.7% |
| 46 | ACOGALPHA COGNITION INC | 836,259 | $6.0M | 0.7% |
| 47 | KYMRKYMERA THERAPEUTICS INCPUT | 50,400 | $5.8M | 0.6% |
| 48 | HROWHARROW INC | 135,775 | $5.8M | 0.6% |
| 49 | KZIAKAZIA THERAPEUTICS LTD | 396,201 | $5.6M | 0.6% |
| 50 | RAREULTRAGENYX PHARMACEUTICAL IN | 165,617 | $5.5M | 0.6% |
| 51 | QTTBQ32 BIO INC | 430,000 | $5.5M | 0.6% |
| 52 | TENXTENAX THERAPEUTICS INCCALL | 373,100 | $5.4M | 0.6% |
| 53 | EPRXEUPRAXIA PHARMACEUTICALS INC | 809,741 | $5.4M | 0.6% |
| 54 | EYPTEYEPOINT INCPUT | 370,400 | $5.3M | 0.6% |
| 55 | EYPTEYEPOINT INCCALL | 370,400 | $5.3M | 0.6% |
| 56 | SLSSELLAS LIFE SCIENCES GROUP IPUT | 354,700 | $5.2M | 0.6% |
| 57 | BIOABIOAGE LABS INC | 200,000 | $4.9M | 0.5% |
| 58 | RZLTREZOLUTE INC | 935,012 | $4.9M | 0.5% |
| 59 | OLMAOLEMA PHARMACEUTICALS INC | 383,281 | $4.8M | 0.5% |
| 60 | SIONSIONNA THERAPEUTICS INCPUT | 107,500 | $4.7M | 0.5% |
| 61 | MNPRMONOPAR THERAPEUTICS INC | 47,861 | $4.4M | 0.5% |
| 62 | BBIOBRIDGEBIO PHARMA INC | 57,417 | $4.3M | 0.5% |
| 63 | CLDXCELLDEX THERAPEUTICS INC NEWPUT | 114,000 | $4.2M | 0.5% |
| 64 | IVAINVENTIVA SA | 1.1M | $4.2M | 0.4% |
| 65 | ABSIABSCI CORPORATION | 353,772 | $4.1M | 0.4% |
| 66 | ALECALECTOR INC | 2.0M | $4.0M | 0.4% |
| 67 | CLYMCLIMB BIO INC | 300,000 | $3.9M | 0.4% |
| 68 | FULCFULCRUM THERAPEUTICS INC | 1.0M | $3.8M | 0.4% |
| 69 | CRDLCARDIOL THERAPEUTICS INC | 3.3M | $3.5M | 0.4% |
| 70 | CUECUE BIOPHARMA INC | 104,364 | $3.3M | 0.4% |
| 71 | CPIXCUMBERLAND PHARMACEUTICALS I | 503,153 | $3.3M | 0.4% |
| 72 | ARWRARROWHEAD PHARMACEUTICALS IN | 38,278 | $3.1M | 0.3% |
| 73 | VERAVERA THERAPEUTICS INCCALL | 71,700 | $3.1M | 0.3% |
| 74 | RNTXREIN THERAPEUTICS INC | 3.0M | $3.1M | 0.3% |
| 75 | ARVNARVINAS INC | 358,257 | $3.0M | 0.3% |
| 76 | ABOSACUMEN PHARMACEUTICALS INC | 1.1M | $2.8M | 0.3% |
| 77 | PMNPROMIS NEUROSCIENCES INC | 205,000 | $2.7M | 0.3% |
| 78 | QTTBQ32 BIO INCPUT | 200,000 | $2.5M | 0.3% |
| 79 | OLMAOLEMA PHARMACEUTICALS INCCALL | 200,000 | $2.5M | 0.3% |
| 80 | ANNXANNEXON INC | 430,244 | $2.5M | 0.3% |
| 81 | BMYBRISTOL-MYERS SQUIBB COPUT | 42,500 | $2.4M | 0.3% |
| 82 | LXEOLEXEO THERAPEUTICS INC | 513,011 | $2.4M | 0.3% |
| 83 | DCTHDELCATH SYS INC | 185,667 | $2.3M | 0.3% |
| 84 | IVVDINVIVYD INC | 2.7M | $2.3M | 0.2% |
| 85 | UNIQURE NVCALL | 49,800 | $2.3M | 0.2% |
| 86 | CABACABALETTA BIO INC | 700,000 | $2.2M | 0.2% |
| 87 | NMRANEUMORA THERAPEUTICS INC. | 1.3M | $2.2M | 0.2% |
| 88 | AMLXAMYLYX PHARMACEUTICALS INC | 117,500 | $2.1M | 0.2% |
| 89 | TARSTARSUS PHARMACEUTICALS INC | 31,166 | $2.0M | 0.2% |
| 90 | SLNSILENCE THERAPEUTICS PLC | 830,784 | $1.8M | 0.2% |
| 91 | DERMJOURNEY MED CORP | 251,436 | $1.8M | 0.2% |
| 92 | DBVTDBV TECHNOLOGIES S A | 525,000 | $1.7M | 0.2% |
| 93 | IBIOIBIO INC | 957,062 | $1.7M | 0.2% |
| 94 | AVTXAVALO THERAPEUTICS INC | 90,183 | $1.7M | 0.2% |
| 95 | AVRANTERIS TECHNOLOGIES GLOBAL | 166,571 | $1.6M | 0.2% |
| 96 | PALIPALISADE BIO INC | 750,000 | $1.6M | 0.2% |
| 97 | AMANAT ACQUISITION CORP | 150,000 | $1.5M | 0.2% |
| 98 | KLRSKALARIS THERAPEUTICS INC | 360,000 | $1.5M | 0.2% |
| 99 | QNCXQUINCE THERAPEUTICS INC | 72,251 | $1.3M | 0.1% |
| 100 | LPCNLIPOCINE INC NEW | 508,556 | $1.3M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.